Cincinnati Man Beats Rare Disease With Experimental Therapy

Michael Lomonaco discovered something was terribly wrong when working out alongside his son made him feel worse, not better. The Cincinnati fitness enthusiast was preparing his son for Air Force training in 2024, but instead of building strength, he faced growing fatigue and shortness of breath.

Doctors eventually diagnosed the 55-year-old with AL amyloidosis, a rare disease where abnormal proteins attack vital organs. For someone who thrived on the energy exercise gave him, the diagnosis threatened everything he loved about his active lifestyle.

Rather than dwelling on fear, Lomonaco focused forward. "It was more, 'All right, this is the path I'm on, then what's next?'" he said.

When traditional treatments failed to produce results, Lomonaco became one of the first patients in Ohio to try CAR T-cell therapy for his condition. The experimental treatment modifies a patient's own immune cells to hunt down and destroy harmful cells.

Dr. Naresh Bumma of The Ohio State University explained that the therapy essentially trains the body's immune system to recognize and attack disease. The cells are removed, modified in a lab, then returned to the patient as targeted fighters.

The stakes were particularly high for Lomonaco. Patients with advanced cardiac involvement from amyloidosis typically survive only six to 12 months, maybe two years at best.

In February, Lomonaco received the news that changed everything. His health had significantly improved, and he could return to the activities that defined his life.

The real test came at his son's wedding a couple months back. "I was able to go to his wedding and dance with him and dance with my wife," Lomonaco said. "I can go as long as I want now, pretty much."

Why This Inspires

Lomonaco's story shows how experimental treatments are turning death sentences into second chances. His willingness to try an unproven therapy as one of Ohio's first patients helped advance medical science while saving his own life.

Beyond the medical breakthrough, his approach to crisis offers its own lesson. Instead of anger or despair, he chose forward momentum and became part of the solution.

Now Lomonaco is back to the workouts that once revealed his illness, except this time they're building him up exactly as they should. He's living proof that the future of medicine is arriving faster than we think, and that staying open to new possibilities can mean the difference between giving up and dancing at your son's wedding.